Accessibility Menu
Surgical Science Sweden Ab (publ) logo

Surgical Science Sweden Ab (publ)(OTC) SUSRF

Market Cap$204.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-71%
5 Year-71%
1 Year-74%
1 Month+0%
$4.00
-2.20%
-0.09Today
Surgical Science Sweden Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 4.002026-07-20
Surgical Science Sweden Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 4.002026-07-07
1 month+0%USD 4.002026-06-18
3 month+40.85%USD 2.842026-02-12
Year to date+17.3%USD 3.412025-12-29
1 year-73.51%USD 15.102025-06-13
3 year-73.24%USD 14.952023-07-17
5 year-70.7%USD 13.652021-05-28
Since inception-71.49%USD 14.032021-01-21

Surgical Science Sweden Ab (publ) Financials at a Glance

Market Cap

$204.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 976.46M

Net Income (TTM)

SEK 52.12M

EPS (TTM)

$0.11

P/E Ratio

36.20

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$4.00

Volume

40

Open

$4.00

Previous Close

$4.00

Daily Range

$4.00 - $4.00

52-Week Range

$2.84 - $15.47

Estimated Earnings Date

Aug 19, 2026

SUSRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surgical Science Sweden Ab (publ)

Surgical Science Sweden AB specializes in developing advanced simulators for laparoscopic medical training. The company offers innovative solutions that enhance surgical education and improve patient outcomes through realistic training experiences.

Products and Services
  • LapSim for procedural simulation in various surgical specialties
  • EndoSim for endoscopy simulation training
  • TeamSim for collaborative surgical team training
Growth Outlook
  • Revenue of 235 million SEK in Q1 2026, showing strong demand
  • Gross profit margin of 65.8% in Q1 2026, indicating efficient operations
  • Significant cash reserves of 667 million SEK, supporting future growth initiatives
Financial Highlights
  • Net income of 18.6 million SEK in Q1 2026, reflecting profitability
  • Operating income margin of 9.7% in Q1 2026, showcasing operational efficiency
  • Current ratio of 4.44, indicating strong liquidity position
Surgical Science Sweden AB is positioned in the healthcare sector, focusing on medical specialties. The company has demonstrated a commitment to innovation in surgical training, which is critical in a rapidly evolving medical landscape. The recent quarterly results highlight a robust revenue stream and profitability, suggesting a solid foundation for future growth. The strong cash position allows for potential investments in research and development, further enhancing product offerings. With a focus on improving surgical education, Surgical Science Sweden AB presents an intriguing opportunity for investors interested in the healthcare technology sector.
AI Generated • Jul 29, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

317

CEO

Tom Englund

Website

www.surgical-science.com

Headquarters

Gothenburg, VG 412 50, SE

SUSRF Financials

Key Financial Metrics (TTM)

Gross Margin

63.12%

Operating Margin

7.65%

Net Income Margin

5.34%

Return on Equity

1.21%

Return on Capital

2.55%

Return on Assets

1.09%

Earnings Yield

2.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$204.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

51.03M

Volume

40

Avg. Volume

8.762

Financials (TTM)

Gross Profit

SEK 616.41M

Operating Income

SEK 74.62M

EBITDA

SEK 125.24M

Operating Cash Flow

SEK 149.87M

Capital Expenditure

-SEK 47.70M

Free Cash Flow

SEK 102.17M

Cash & ST Invst.

SEK 667.73M

Total Debt

SEK 2.15M

Surgical Science Sweden Ab (publ) Performance Analysis

Surgical Science Sweden Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 79,303,20785.6%
20232023-12-31SEK 83,162,9304.9%
20242024-12-31SEK 83,619,5500.5%
20252025-12-31SEK 101,182,06521.0%
Surgical Science Sweden Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-16.6%
Q32025-09-3026.0%
Q42025-12-311.7%
Q12026-03-31-12.2%
Surgical Science Sweden Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK 0.3654.9%
20232023-12-31SEK 0.4318.6%
20242024-12-31SEK 0.24-43.6%
20252025-12-31SEK 0.13-45.3%
Surgical Science Sweden Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-160.0%
Q32025-09-30202.6%
Q42025-12-3162.5%
Q12026-03-31-44.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 235.48M

-6.1%

Gross Profit

SEK 154.97M

-10.2%

Gross Margin

65.81%

N/A

Market Cap

$204.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$652.09K

N/A

Employees

313

N/A

Net Income

SEK 18.63M

-44.0%

EBITDA

SEK 49.61M

+107.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 667.73M

+8.9%

Total Debt

SEK 2.15M

+30.5%

Accounts Receivable

SEK 122.83M

-17.2%

Inventory

SEK 207.50M

+10.4%

Long Term Debt

SEK 0.00

N/A

Short Term Debt

SEK 2.15M

+30.5%

Return on Assets

1.09%

N/A

Return on Invested Capital

1.65%

N/A

Free Cash Flow

SEK 47.35M

+402.5%

Operating Cash Flow

SEK 65.31M

+1417.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BOVNFBioInvent International AB (publ)
$3.29+0.00%
COGZFCogstate Limited
$1.75+0.00%
VHIBFVitalhub Corp.
$4.89-0.31%
PTCHFPureTech Health plc
$1.53+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About SUSRF

What is the current price of Surgical Science Sweden Ab (publ)?

Surgical Science Sweden Ab (publ) is trading at $4.00 per share.

What is the 52-week range for Surgical Science Sweden Ab (publ)?

Over the past 52 weeks, Surgical Science Sweden Ab (publ) has traded between $2.84 and $15.47.

How much debt does Surgical Science Sweden Ab (publ) have?

As of the most recent reporting period, Surgical Science Sweden Ab (publ) reported total debt of SEK 225.27K.

How much cash does Surgical Science Sweden Ab (publ) have on hand?

Surgical Science Sweden Ab (publ) reported SEK 70.09M in cash and cash equivalents in its most recent financial results.

What is Surgical Science Sweden Ab (publ)’s dividend yield?

Surgical Science Sweden Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services